Strontium 90 (90Sr) remains in the environment long after a major nuclear disaster occurs. As a result, populations living on contaminated land are potentially exposed to daily ingesting of low quantities of 90Sr. The potential long-term health effects of such chronic contamination are unknown. In this study, we used a mouse model to evaluate the effects of 90Sr ingestion on the immune system, the animals were chronically exposed to 90Sr in drinking water at a concentration of 20 kBq/l, for a daily ingestion of 80–100 Bq/day. This resulted in a reduced number of CD19+ B lymphocytes in the bone marrow and spleen in steady-state conditions. In contrast, the results from a vaccine experiment performed as a functional test of the immune system showed that in response to T-dependent antigens, there was a reduction in IgG specific to tetanus toxin (TT), a balanced Th1/Th2 response inducer antigen, but not to keyhole limpet hemocyanin (KLH), a strong Th2 response inducer antigen. This was accompanied by a reduction in Th1 cells in the spleen, consistent with the observed reduction in specific IgG concentration. The precise mechanisms by which 90Sr acts on the immune system remain to be elucidated. However, our results suggest that 90Sr ingestion may be responsible for some of the reported effects of internal contamination on the immune system in civilian populations exposed to the Chernobyl fallout.
Skip Nav Destination
Close
Article navigation
1 March 2016
Research Article|
March 01 2016
Immune System Modifications Induced in a Mouse Model of Chronic Exposure to 90Sr
Nicholas Synhaeve
;
Nicholas Synhaeve
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
1Current address: ExxonMobil Petroleum and Chemical/Biomedical Sciences, Inc., Hermeslaan 2, 1831 Machelen, Belgium.
Search for other works by this author on:
Stefania Musilli
;
Stefania Musilli
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
Search for other works by this author on:
Johanna Stefani
;
Johanna Stefani
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
Search for other works by this author on:
Nour Nicolas
;
Nour Nicolas
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
Search for other works by this author on:
Olivia Delissen
;
Olivia Delissen
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
Search for other works by this author on:
Isabelle Dublineau
;
Isabelle Dublineau
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
Search for other works by this author on:
Jean-Marc Bertho
Jean-Marc Bertho
2
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE, LRTOX, Fontenay-aux-Roses, F-92262, France
2Address for correspondence: IRSN, DRPH/SRBE/LRTOX, BP no. 17, F-92262 Fontenay aux Roses cedex, France; email: jean-marc.bertho@irsn.fr.
Search for other works by this author on:
Radiat Res (2016) 185 (3): 267–284.
Article history
Received:
January 01 2015
Accepted:
January 01 2016
Citation
Nicholas Synhaeve, Stefania Musilli, Johanna Stefani, Nour Nicolas, Olivia Delissen, Isabelle Dublineau, Jean-Marc Bertho; Immune System Modifications Induced in a Mouse Model of Chronic Exposure to 90Sr. Radiat Res 1 March 2016; 185 (3): 267–284. doi: https://doi.org/10.1667/RR14014.1
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner